Literature DB >> 7887939

Antiviral activity and metabolism of the castanospermine derivative MDL 28,574, in cells infected with herpes simplex virus type 2.

S P Ahmed1, R J Nash, C G Bridges, D L Taylor, M S Kang, E A Porter, A S Tyms.   

Abstract

The 6-O-butanoyl derivative of castanospermine (MDL 28,574: BUCAST), an inhibitor of glycoprotein processing, blocked the growth of herpes simplex virus type-2 with the effect markedly enhanced by exposure of cells to the compound pre- as well as post-infection. The effectiveness of the derivative corresponded to an increased uptake with greatest accumulation after virus infection. Gas chromatography/mass spectrometry identified the predominant component in MDL 28,574 treated cells as castanospermine, an inhibitor of alpha-glucosidase 1. The effects of this compound on the synthesis of viral glycoprotein, gB, was determined with the increased molecular weight of the mannose-rich precursor evidence for the modulation of glycoprotein processing.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7887939     DOI: 10.1006/bbrc.1995.1333

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Identification of the Polyketide Biosynthetic Machinery for the Indolizidine Alkaloid Cyclizidine.

Authors:  Wei Huang; Seong Jong Kim; Joyce Liu; Wenjun Zhang
Journal:  Org Lett       Date:  2015-10-16       Impact factor: 6.005

2.  Glycosylation, hypogammaglobulinemia, and resistance to viral infections.

Authors:  Mohammed A Sadat; Susan Moir; Tae-Wook Chun; Paolo Lusso; Gerardo Kaplan; Lynne Wolfe; Matthew J Memoli; Miao He; Hugo Vega; Leo J Y Kim; Yan Huang; Nadia Hussein; Elma Nievas; Raquel Mitchell; Mary Garofalo; Aaron Louie; Derek C Ireland; Claire Grunes; Raffaello Cimbro; Vyomesh Patel; Genevieve Holzapfel; Daniel Salahuddin; Tyler Bristol; David Adams; Beatriz E Marciano; Madhuri Hegde; Yuxing Li; Katherine R Calvo; Jennifer Stoddard; J Shawn Justement; Jerome Jacques; Debra A Long Priel; Danielle Murray; Peter Sun; Douglas B Kuhns; Cornelius F Boerkoel; John A Chiorini; Giovanni Di Pasquale; Daniela Verthelyi; Sergio D Rosenzweig
Journal:  N Engl J Med       Date:  2014-04-09       Impact factor: 91.245

3.  Diastereoselective nitrenium ion-mediated cyclofunctionalization: total synthesis of (+)-castanospermine.

Authors:  Edward G Bowen; Duncan J Wardrop
Journal:  Org Lett       Date:  2010-10-21       Impact factor: 6.005

Review 4.  Glycans Instructing Immunity: The Emerging Role of Altered Glycosylation in Clinical Immunology.

Authors:  Jonathan J Lyons; Joshua D Milner; Sergio D Rosenzweig
Journal:  Front Pediatr       Date:  2015-06-11       Impact factor: 3.418

Review 5.  Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents.

Authors:  Jinhong Chang; Ju-Tao Guo; Yanming Du; Timothy Block
Journal:  Emerg Microbes Infect       Date:  2013-11-20       Impact factor: 7.163

Review 6.  Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus.

Authors:  Joanna L Miller; Beatrice E Tyrrell; Nicole Zitzmann
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 7.  Genetic diseases conferring resistance to infectious diseases.

Authors:  Isabelle C Withrock; Stephen J Anderson; Matthew A Jefferson; Garrett R McCormack; Gregory S A Mlynarczyk; Aron Nakama; Jennifer K Lange; Carrie A Berg; Sreemoyee Acharya; Matthew L Stock; Melissa S Lind; K C Luna; Naveen C Kondru; Sireesha Manne; Bhavika B Patel; Bierlein M de la Rosa; Kuei-Pin Huang; Shaunik Sharma; Hilary Z Hu; Sri Harsha Kanuri; Steve A Carlson
Journal:  Genes Dis       Date:  2015-02-25

Review 8.  Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.

Authors:  Jinhong Chang; Timothy M Block; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2013-06-29       Impact factor: 5.970

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.